Growth Factor Changes in Cerebrospinal Fluid of Children with Mental Retardation before and after Neural Precursor...

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biochemistry

Background:

• Mental retardation (MR) presents complex challenges in pediatric care.
• Neural precursor cell transplantation (NPCT) is an emerging therapeutic strategy for MR.
• Understanding the biological mechanisms underlying NPCT is crucial for optimizing treatment.

Purpose of the Study:

• To investigate changes in growth factors within the cerebrospinal fluid (CSF) of children with MR.
• To evaluate the impact of NPCT on these growth factors.
• To explore the correlation between growth factor alterations and short-term therapeutic effects of NPCT.

Main Methods:

• The study involved 28 children diagnosed with MR undergoing twice NPCT.
• Cerebrospinal fluid (CSF) samples were collected before and after each NPCT procedure.
• Enzyme-linked immunosorbent assay (ELISA) was used to measure growth factors, with a specific focus on insulin-like growth factor 1 (IGF-1).

Main Results:

• Insulin-like growth factor 1 (IGF-1) was the only growth factor showing a significant increase in CSF post-NPCT (P<0.05).
• Children who exhibited short-term therapeutic efficacy (15/28) had significantly higher IGF-1 levels post-NPCT compared to pre-NPCT levels (P<0.05).
• Children without short-term therapeutic effects (13/28) showed no significant difference in IGF-1 levels before and after NPCT (P=0.657), with significant differences in IGF-1 change between the two groups (P<0.05).

Conclusions:

• IGF-1 elevation in CSF following NPCT is a significant finding.
• The increase in IGF-1 appears to be closely associated with positive short-term therapeutic outcomes in MR patients treated with NPCT.
• IGF-1 may represent a key mechanistic factor contributing to the therapeutic benefits of NPCT for mental retardation.